{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["12"],"submitter":["Omer S"],"pubmed_abstract":["SARS-CoV-2 is a causative agent for COVID-19 disease, initially reported from Wuhan, China. The infected patients experienced mild to severe symptoms, resulting in several fatalities due to a weak understanding of its pathogenesis, which is the same even to date. This cross-sectional study has been designed on 452 symptomatic mild-to-moderate and severe/critical patients to understand the epidemiology and clinical characteristics of COVID-19 patients with their comorbidities and response to treatment. The mean age of the studied patients was 58 ± 14.42 years, and the overall male to female ratio was 61.7 to 38.2%, respectively. In total, 27.3% of the patients had a history of exposure, and 11.9% had a travel history, while for 60% of patients, the source of infection was unknown. The most "],"journal":["Frontiers in cellular and infection microbiology"],"pagination":["800511"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9226825"],"repository":["biostudies-literature"],"pubmed_title":["Epidemiology, Clinico-Pathological Characteristics, and Comorbidities of SARS-CoV-2-Infected Pakistani Patients."],"pmcid":["PMC9226825"],"pubmed_authors":["Omer S","Akram J","Shahzad F","Afzal N","Gondal MF","Khan A","Tahir R","Jahan S","Faizan RM","Qaiser TA","Ayub S","Naveed MA","Usman M","Sarwar MB","Yasir M","Roman M"],"additional_accession":[]},"is_claimable":false,"name":"Epidemiology, Clinico-Pathological Characteristics, and Comorbidities of SARS-CoV-2-Infected Pakistani Patients.","description":"SARS-CoV-2 is a causative agent for COVID-19 disease, initially reported from Wuhan, China. The infected patients experienced mild to severe symptoms, resulting in several fatalities due to a weak understanding of its pathogenesis, which is the same even to date. This cross-sectional study has been designed on 452 symptomatic mild-to-moderate and severe/critical patients to understand the epidemiology and clinical characteristics of COVID-19 patients with their comorbidities and response to treatment. The mean age of the studied patients was 58 ± 14.42 years, and the overall male to female ratio was 61.7 to 38.2%, respectively. In total, 27.3% of the patients had a history of exposure, and 11.9% had a travel history, while for 60% of patients, the source of infection was unknown. The most ","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-04T08:47:37.082Z","creation":"2025-04-04T08:47:37.082Z"},"accession":"S-EPMC9226825","cross_references":{"pubmed":["35755851"],"doi":["10.3389/fcimb.2022.800511"]}}